1 option
Pediatric Research Products Studied Under Two Related Laws, but Improved Tracking Needed by FDA
ProQuest Congressional Research Digital Collection: Part C (2011 forward) Available online
View online- Format:
- Book
- Government document
- Author/Creator:
- United States. Government Accountability Office
- Language:
- English
- Subjects (All):
- Children.
- Drugs.
- Labels.
- Physical Description:
- 1 online resource
- Contained In:
- ProQuest U.S. Congressional Research Digital Collection
- Place of Publication:
- [United States] [publisher not identified] 2011
- Summary:
- Report describing effects of the Pediatric Research Equity Act and the Best Pharmaceuticals for Children Act since reauthorization in 2007, including examining how many and what types of drug products have been studied, reviewing number and type of labeling changes and related FDA review periods, and assessing challenges identified by stakeholders to conducting studies
- Notes:
- Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Feb. 2013). Reuse except for individual research requires license from ProQuest, LLC
- Vendor supplied data
- Other Format:
- Microfiche version United States. Government Accountability Office. Pediatric Research:. 2011 J942-210
- Publisher Number:
- CMP-2011-GAO-0206
- Access Restriction:
- Restricted for use by site license
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.